UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF INCOME AND COMPREHENSIVE INCOME - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Total revenue	$ 638.9	$ 608.9	$ 1,822.3	$ 1,734.4
Total cost of revenue	303.6	300.2	882.5	866.4
Gross profit	335.3	308.7	939.8	868.0
Operating expenses:
Selling, general and administrative	144.8	141.3	442.7	407.9
Research and development	56.2	52.1	172.4	162.7
Other charges, net	3.0	2.1	23.0	9.5
Total operating expenses	204.0	195.5	638.1	580.1
Operating income	131.3	113.2	301.7	287.9
Interest and other income (expense), net	(2.0)	(4.4)	(8.8)	(13.8)
Income before income taxes, equity in income of unconsolidated investee, net of tax, and noncontrolling interests in consolidated subsidiaries	129.3	108.8	292.9	274.1
Income tax provision	41.2	20.7	93.0	69.5
Equity in income of unconsolidated investee, net of tax	0.3	0.0	0.3	0.0
Consolidated net income	88.4	88.1	200.2	204.6
Net income attributable to noncontrolling interests in consolidated subsidiaries	0.3	1.0	1.0	3.2
Net income attributable to Bruker Corporation	$ 88.1	$ 87.1	$ 199.2	$ 201.4
Net income per common share attributable to Bruker Corporation shareholders:
Basic	$ 0.60	$ 0.58	$ 1.34	$ 1.33
Diluted	$ 0.59	$ 0.57	$ 1.33	$ 1.32
Weighted average common shares outstanding:
Basic (in shares)	147.8	151.4	149.1	151.5
Diluted (in shares)	148.6	152.8	149.9	153.0
Comprehensive income	$ 44.6	$ 73.1	$ 113.7	$ 188.1
Less: Comprehensive (loss) income attributable to noncontrolling interests	(0.3)	0.7	(0.5)	0.9
Less: Comprehensive loss attributable to redeemable noncontrolling interest	(0.6)	0.0	(1.3)	0.0
Comprehensive income attributable to Bruker Corporation	45.5	72.4	115.5	187.2
Product
Total revenue	536.6	508.3	1,512.8	1,441.2
Total cost of revenue	240.5	243.5	699.6	700.4
Service
Total revenue	100.9	99.0	305.0	287.8
Total cost of revenue	63.1	56.5	182.8	165.3
Other
Total revenue	1.4	1.6	4.5	5.4
Total cost of revenue	$ 0.0	$ 0.2	$ 0.1	$ 0.7